The American Society for Investigative Pathology has announced it will honor Qin Yan, PhD, Associate Professor of Pathology at Yale School of Medicine, with its 2023 Outstanding Investigator Award.
The award recognizes mid-career investigators with demonstrated excellence in research in experimental pathology. The American Society for Investigative Pathology (ASIP) is a society of biomedical scientists who investigate mechanisms of disease. The awards committee considers the candidate’s published record of peer-reviewed research and overall impact of the candidate’s science, mentorship, and participation in ASIP scientific meetings.
Dr. Yan’s laboratory at Yale School of Medicine recently discovered that the CECR2 gene drives the progression and metastasis of breast cancer by suppressing the immune system. In addition, he and Marcus Bosenberg, MD, PhD, were honored earlier this year for their research into KDM5B, a key enzyme in epigenetic regulation. This finding has been highlighted as one of the Breakthroughs at Yale Cancer Center.
“Congratulations to Dr. Yan for this well-deserved recognition,” said Chen Liu, MD, PhD, Chair of Yale Pathology. “Dr. Yan is a tireless investigator and an enthusiastic colleague, and I expect his groundbreaking work will lead to treatment advances and pharmacological breakthroughs.”
The award was announced at the ASIP’s Annual Meeting at Experimental Biology 2022 held on April 2-5 in Philadelphia. Dr. Yan will receive the award at ASIP’s 2023 Annual Meeting in October 2023 in Salt Lake City, where he will deliver the Award Lecture.
Dr. Yan is also Co-Leader of Yale Cancer Center’s Genomics, Genetics and Epigenetics Research Program, Director of the Center for Epigenetics and Biomarkers at Yale Pathology, and Scientific Co-Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center.